Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

2.6K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.6K
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

2.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interpersonal stress, epigenetic indices of inflammation, and depressive symptoms: Longitudinal associations from adolescence to young adulthood.

Neurobiology of stress·2026
Same author

Developmental Trauma as a Prognostic Factor for Later Psychotic Disorder in an Adolescent Clinical Cohort: A 20-Year Follow Up Study.

Acta psychiatrica Scandinavica·2026
Same author

Impact of sex differences on the association between clinical predictors and electroconvulsive therapy outcomes: results from the Dutch ECT Consortium (DEC).

Journal of affective disorders·2026
Same author

Co-expression-based models improve eQTL predictions for transcriptome-wide association studies and highlight new schizophrenia-associated genes.

Nature genetics·2026
Same author

Clusters of social and substance use-related risks are associated with the duration of untreated psychosis.

Psychological medicine·2026
Same author

Remote Magnetomechanical Neuromodulation Uncovers Therapeutic Mechanisms for Alleviating Parkinsonian Symptoms in Freely Moving Mice.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Related Experiment Video

Updated: Apr 30, 2026

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

11.7K

The immune system and electroconvulsive therapy for depression.

Sinan Guloksuz1, Bart P F Rutten, Baer Arts

  • 1From the *Department of Psychiatry and Psychology, Centre of Contextual Neuroscience, Maastricht University Medical Centre, EURON, Maastricht, The Netherlands; †Department of Psychiatry, Yale University Medical School, New Haven, CT and ‡King's College London, King's Health Partners, Department of Psychosis Studies, Institute of Psychiatry, London, UK.

The Journal of ECT
|April 24, 2014
PubMed
Summary

Electroconvulsive therapy (ECT) may impact the immune system, with single sessions causing temporary activation and repeated treatments leading to long-term immune down-regulation. Further research is needed to confirm these findings and understand ECT's therapeutic mechanisms.

More Related Videos

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

31.9K
Neuroimaging-Guided TMS–EEG for Real-Time Cortical Network Mapping
09:55

Neuroimaging-Guided TMS–EEG for Real-Time Cortical Network Mapping

Published on: June 13, 2025

3.0K

Related Experiment Videos

Last Updated: Apr 30, 2026

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

11.7K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

31.9K
Neuroimaging-Guided TMS–EEG for Real-Time Cortical Network Mapping
09:55

Neuroimaging-Guided TMS–EEG for Real-Time Cortical Network Mapping

Published on: June 13, 2025

3.0K

Area of Science:

  • Neuroscience
  • Immunology
  • Psychiatry

Background:

  • Electroconvulsive therapy (ECT) is a highly effective treatment for severe psychiatric disorders like treatment-resistant depression.
  • The precise mechanisms underlying ECT's therapeutic effects remain largely unknown.
  • Emerging evidence suggests potential links between immune system disturbances and depression, as well as the hypothalamic-pituitary-adrenal axis modulation by ECT.

Purpose of the Study:

  • To review existing literature on the effects of electroconvulsive therapy (ECT) on the immune system.
  • To explore the potential role of immune system alterations in mediating ECT's therapeutic actions.

Main Methods:

  • A literature search was conducted using PubMed/Medline for studies on ECT, inflammation, and the immune system.
  • Studies investigating ECT-induced changes in immune function and their potential mechanistic role were summarized.

Main Results:

  • A limited number of studies were identified, indicating that a single ECT session can acutely activate the immune system transiently.
  • Repetitive ECT treatments appear to result in a long-term down-regulation of immune activation.
  • Inconsistencies in findings and methodological limitations (e.g., small sample sizes, unaddressed confounding factors) hinder definitive conclusions.

Conclusions:

  • More rigorous, prospective, and controlled studies with larger sample sizes are necessary.
  • Further research is required to fully elucidate the role of immunological changes in mediating the therapeutic effects of ECT.